je.st
news
Home
›
Cancer Genetics Expands BioDiscovery's Nexus Copy Number Platform to Identify Novel Biomarkers ...
Cancer Genetics Expands BioDiscovery's Nexus Copy Number Platform to Identify Novel Biomarkers ...
2014-04-02 06:00:00| Industrial Newsroom - All News for Today
Hawthorne, CA and Rutherford, NJ – Cancer Genetics, Inc. (Nasdaq: CGIX) and BioDiscovery, Inc. have announced expansion of the Nexus Copy Number Discovery platform in CGI research to uncover novel biomarkers which are predictive of cancer outcomes.<br /> <br /> "Cancer Genetics has been able to leverage the Nexus Copy Number platform's unique ability to quickly digest large data sets to uncover correlations between genomic events and clinical factors in their discovery efforts," says ...This story is related to the following:Data Analysis Software |
Tags: number
copy
identify
cancer
Category:Industrial Goods and Services
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||